Evidence map›Paper›PMID 40894198›Full record

ArticleFrontiers in pharmacology2025

Kangshujiangu granules improve NAFLD via cross-organ autophagy activation shared with osteoporosis.

Ningxi Wang, Li Song, Yue Peng, Langqiu Wei, Zhaofan Long, Che Wang, Qiling Liu, Chuandao Shi

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ningxi Wang *School of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Li Song *School of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Yue PengGuangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Langqiu WeiSchool of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Zhaofan LongSchool of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Che WangSchool of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Qiling LiuSchool of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.
Chuandao ShiSchool of Public Health, Shaanxi University of Chinese Medicine, Xianyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Osteoporosis (OP), an age-related skeletal disorder characterized by reduced bone mass and deteriorated microarchitecture, and non-alcoholic fatty liver disease (NAFLD), a metabolic condition primarily driven by obesity and insulin resistance (with age as a modifying factor), were investigated in this study. We aimed to elucidate the correlation between OP and NAFLD-associated lipid metabolism, and determine the therapeutic effects and molecular mechanisms of Kangshujiangu granules (KSJG) on NAFLD pathogenesis. Methods: Clinical study: 261 patients were stratified by OP T-scores into OP and non-OP groups. Bone density, lipid profiles, and liver function were analyzed for NAFLD-OP correlations. Results: Clinical findings: Osteoporosis prevalence exhibited age-dependent elevation. Age, BMI, TC, and TG as independent risk factors for OP ( Conclusion: OP exhibited a negative correlation with lipid metabolism indexes of NAFLD. Bilateral ovariectomy (OVX) simultaneously induced OP and NAFLD, while KSJG granules ameliorated lipid dysregulation via autophagy modulation. KSJG granules enhanced autophagy activation through the AMPK/ULK1 (Ser555) pathway, thereby alleviating NAFLD-associated lipid metabolic disturbances.

Indexed as

AMPK/mTOR/ULK1 pathwayautophagyKangshujiangu granulesnon-alcoholic fatty liver diseaseosteoporosis

Identifiers

PMID40894198
PMCPMC12391095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.